<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in GlioblastomaMonika E. Hegi, Roger Stupp|New England Journal of Medicine|2005Cited by 7.2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Wolfgang Wick, Martin J. van den Bent et al.|Nature Reviews Clinical Oncology|2020Cited by 1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y. Wen, Martin J. van den Bent, Evanthia Galanis et al.|Neuro-Oncology|2020Cited by 1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialMark R. Gilbert, Minesh P. Mehta, Meihua Wang et al.|Journal of Clinical Oncology|2013Cited by 1.1k
Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT ActivityMonika E. Hegi, Mark R. Gilbert, Lili Liu et al.|Journal of Clinical Oncology|2008Cited by 805